[Preventative and therapeutic relapse strategies after allogeneic hematopoietic stem cell transplantation: Guidelines from the Francophone society of bone marrow transplantation and cellular therapy (SFGM-TC)].
Yafour, Nabil
[Preventative and therapeutic relapse strategies after allogeneic hematopoietic stem cell transplantation: Guidelines from the Francophone society of bone marrow transplantation and cellular therapy (SFGM-TC)]. [electronic resource] - Bulletin du cancer Dec 2017 - S84-S98 p. digital
Publication Type: Journal Article; Practice Guideline; Review
1769-6917
10.1016/j.bulcan.2017.05.009 doi
Antineoplastic Agents--therapeutic use
Bortezomib--therapeutic use
Central Nervous System Neoplasms--prevention & control
Genetic Markers
Hematologic Neoplasms--genetics
Hematopoietic Stem Cell Transplantation
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy
Lymphoma--drug therapy
Maintenance Chemotherapy--standards
Multiple Myeloma--drug therapy
Neoplasm, Residual
Prognosis
Protein Kinase Inhibitors--therapeutic use
Recurrence
Retreatment--methods
Secondary Prevention--methods
[Preventative and therapeutic relapse strategies after allogeneic hematopoietic stem cell transplantation: Guidelines from the Francophone society of bone marrow transplantation and cellular therapy (SFGM-TC)]. [electronic resource] - Bulletin du cancer Dec 2017 - S84-S98 p. digital
Publication Type: Journal Article; Practice Guideline; Review
1769-6917
10.1016/j.bulcan.2017.05.009 doi
Antineoplastic Agents--therapeutic use
Bortezomib--therapeutic use
Central Nervous System Neoplasms--prevention & control
Genetic Markers
Hematologic Neoplasms--genetics
Hematopoietic Stem Cell Transplantation
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy
Lymphoma--drug therapy
Maintenance Chemotherapy--standards
Multiple Myeloma--drug therapy
Neoplasm, Residual
Prognosis
Protein Kinase Inhibitors--therapeutic use
Recurrence
Retreatment--methods
Secondary Prevention--methods